Persistent vascular collagen accumulation alters hemodynamic recovery from chronic hypoxia.
暂无分享,去创建一个
Naomi C Chesler | Robert C Molthen | Zhijie Wang | N. Chesler | D. Tabima | T. Hacker | R. Molthen | A. Roldán-Alzate | Diana M Tabima | Alejandro Roldan-Alzate | Zhijie Wang | Timothy A Hacker
[1] M. Pfeffer,et al. Measurement of aortic input impedance in rats. , 1994, The American journal of physiology.
[2] Naomi C Chesler,et al. Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension. , 2005, American journal of physiology. Heart and circulatory physiology.
[3] Robert Molthen,et al. Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function. , 2011, Journal of applied physiology.
[4] N. Westerhof,et al. Forward and backward waves in the arterial system. , 1972, Cardiovascular research.
[5] C. D. Murray. THE PHYSIOLOGICAL PRINCIPLE OF MINIMUM WORK APPLIED TO THE ANGLE OF BRANCHING OF ARTERIES , 1926, The Journal of general physiology.
[6] Naomi C Chesler,et al. The effects of vasoactivity and hypoxic pulmonary hypertension on extralobar pulmonary artery biomechanics. , 2010, Journal of biomechanics.
[7] H. Champion,et al. A novel right-heart catheterization technique for in vivo measurement of vascular responses in lungs of intact mice. , 2000, American journal of physiology. Heart and circulatory physiology.
[8] Pál Pacher,et al. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats , 2008, Nature Protocols.
[9] G. Mark,et al. Pulmonary vascular changes in scleroderma. , 1978, The American journal of medicine.
[10] N. Chesler,et al. Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops. , 2010, American journal of physiology. Heart and circulatory physiology.
[11] D. Pyne,et al. Endurance training at altitude. , 2009, High altitude medicine & biology.
[12] R. Speich,et al. Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[13] Hugh Gordon,et al. Scleroderma , 1937 .
[14] S. Robbins,et al. Pathologic basis of disease , 1974 .
[15] Zhijie Wang,et al. The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension. , 2010, American journal of physiology. Heart and circulatory physiology.
[16] N. Chesler,et al. Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships. , 2007, Journal of biomechanics.
[17] K. Kangawa,et al. Imaging of the pulmonary circulation in the closed-chest rat using synchrotron radiation microangiography. , 2007, Journal of applied physiology.
[18] R. Mecham,et al. Cellular and molecular mechanisms of pulmonary vascular remodeling. , 1997, Annual review of physiology.
[19] M. Frid,et al. Role of the adventitia in pulmonary vascular remodeling. , 2006, Physiology.
[20] D. Badesch,et al. Pulmonary hypertension associated with connective tissue disease. , 2002, Progress in cardiovascular diseases.
[21] T. Schacker,et al. Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.
[22] R. Silver. Scleroderma. Clinical problems. The lungs. , 1996, Rheumatic diseases clinics of North America.
[23] K. Hunter,et al. Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension. , 2008, American heart journal.
[24] Nico Westerhof,et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. , 2007, Chest.
[25] M. Frid,et al. Hypoxia-induced Pulmonary Vascular Remodeling Cellular and Molecular Mechanisms Reviews , 2022 .
[26] W. O’Brien,et al. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. , 1980, Clinica chimica acta; international journal of clinical chemistry.
[27] C. Conti,et al. An Official Journal of the American Heart Association Pulmonary Arterial Pulse Wave Velocity and Impedance in Man , 2005 .
[28] V. Pullicino. A clinical problem , 1976 .
[29] G. Tsujimoto,et al. α1-Adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension , 2007 .
[30] J. Oh,et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[31] G. Tsujimoto,et al. Alpha1-adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension. , 2007, American journal of physiology. Heart and circulatory physiology.
[32] N. Chesler,et al. The Mechanobiology of Pulmonary Vascular Remodeling in the Congenital Absence of eNOS , 2006, Biomechanics and modeling in mechanobiology.
[33] B. Dahal,et al. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[34] J. Coghlan,et al. The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology , 2001, Current opinion in rheumatology.
[35] J. F. Woessner,et al. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.
[36] D. Schwenke,et al. Imaging of the closed-chest mouse pulmonary circulation using synchrotron radiation microangiography. , 2011, Journal of applied physiology.
[37] J. Shaver,et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). , 1977, Annals of internal medicine.
[38] Barry N. Taylor,et al. Guidelines for Evaluating and Expressing the Uncertainty of Nist Measurement Results , 2017 .
[39] R. Silver. CLINICAL PROBLEMS: The Lungs , 1996 .
[40] P. Anthony. Robbins' Pathologic Basis of Disease , 1990 .
[41] J. Staessen,et al. Progress in cardiovascular diseases: cognitive function in essential hypertension. , 2006, Progress in cardiovascular diseases.
[42] H. Champion,et al. Right heart function and haemodynamics in pulmonary hypertension , 2008, International journal of clinical practice. Supplement.
[43] Naomi C. Chesler,et al. Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension , 2011, Pulmonary circulation.